| TIME | SESSION AND TOPIC | SPEAKER |
|---|---|---|
| 08:00β08:10 | Welcome & Introduction to the Workshop | Dr. (Col) Sandeep Karunakaran Medical Director, Oval Fertility, Hyderabad |
|
The IVF Business Model β Where Medicine Meets Metrics Venture Capital/Private Equity-backed vs Promoter-led Strategies in Fertility Care The session will provide a comprehensive overview of fertility unit economics, including: β’ Revenue streams and patient acquisition funnels β’ Cost centres and operational efficiency β’ CapEx vs OpEx decisions in IVF labs β’ EBITDA, NPS, and other financial and experience KPIs β’ Models for achieving sustainable profitability without compromising care |
||
| 08:10β08:30 | Promoter-led Models β led by clinician-entrepreneurs and founders with a deep clinical vision, focusing on long-term reputation, autonomy, and organic growth. | S Chandrasekhar CEO, Oval Fertility |
| 08:30β08:50 | VC/Private Equity-Driven Models β led by professional financial investors, focused on scalability, EBITDA, brand valuation, and return on investment. | Amit Mangal, Managing Partner Opulix Advisory Services |
| 08:50β09:00 | Select Q&A β 10 minutes | |
| 09:00β09:40 |
New Era Marketing (and Branding) Practical Checklist Major aspects of marketing will be covered in a structural way, so you can take it and apply in your business. A framework-based session along with checklist, document and a supporting AI tool. Will cover CAC/LTV, Budget, Goal setting, core components (media, communication, infra and KPI). Major media esp Google My Business, AEO, SEO, SEM etc we will touch along with ATL, BTL, TTL decision making. A session that will shape your thinking process for new era marketing. Marketing Tool Stack (CRM & Beyond) for Fertility Care Data if used correctly improves personalization and effectiveness. Storing data across the funnel using marketing automation, CRM and other tools to automate follow-ups, streamline patient communication, and increase conversion. How to integrate CRM, EMR, WhatsApp, Call Centers and other tools in a cost-effective manner. See it in a practical setup. |
Aji Issac Mathew CEO & Cofounder TechShu & DMU |
| 09:40β09:50 | Select Q&A β 10 minutes | |
|
Blueprints of Success: Building Fertility Practices That Last Insights from a single-centre IVF pioneer and a multi-site leader, with discussion on challenges, pivots, and lessons learned. |
||
| 09:50β10:10 |
Scaling Without Losing Soul: The Art of Doctor-Led IVF Success Lessons from building a thriving standalone clinic rooted in medical integrity and community trust. |
Sabine Sivadasan Chairman and Managing Director, Sabine Hospital and Research Centre Private Limited, Kerala. |
| 10:10β10:30 |
Scaling Without Losing Soul: The Clinicianβs Role in Scaling IVF Networks How medical leadership drives standardization, team culture, and patient trust across sites. |
Durga.G.Rao Medical Director-Oasis Fertility |
| 10:30β10:40 | Select Q&A β 10 minutes | |
| 10:40β11:00 | Coffee Break | |
| 11:00β11:40 |
Panel Discussion: Scaling Without Losing Soul: The Art of Doctor-Led IVF Success β Lessons from building a thriving standalone clinic rooted in medical integrity and community trust. Panellists: β’ Sures M, CEO Sunfert International Fertility Centre β’ Anubhav Prashant, COO - Apollo Cradle & Apollo Fertility β’ Vinesh Gadhia, CEO Fert9 & Center Executive Director β’ Kiran Gadela, Co-Founder & Managing Director Oasis Fertility β’ Narhari S. Malagaonkar, Director and Chief Fertility Consultant Progenesis IVF β’ Srinivas Madabusi, Chief of International Business,New Initiatives and Director Indira IVF Nepal and Bangladesh β’ Somesh Mittal, CEO ART Fertility Clinics |
Moderators: Dr. (Col) Sandeep Karunakaran Medical Director, Oval Fertility, Hyderabad Dr. Venu Gopal Menon Senior Consultant Birla Fertility and IVF, Thrissur |
| 11:40β12:00 | Reimagining Fertility Clinics as Impact Enterprises: Indiaβs Opportunity | Kiran Gadela Co-Founder and Managing Director, Oasis Fertility |
| 12:00β12:30 | Attracting Equity & Foreign Investment in Fertility Practice β What investors look for in IVF businesses, why some international players hesitate, and how to become acquisition-ready | Ashish Tavildar Associate Director Grant Thornton Bharat LLP |
| 12:30β12:40 | Select Q&A β 10 minutes | |
| 12:40β13:20 |
Panel Discussion: From Practice to Network Enterprise: Structuring IVF clinic governance, corporate organizational framework and IVF business models Panellists: β’ Rita Vassena, Medical Director, CooperSurgical; Executive Board Member, SEF β’ Alex C Varghese, Director β Research & Innovation, Fertility Associates, New Zealand β’ Dr. (Col) Sandeep Karunakaran, Medical Director, Oval Fertility, Hyderabad β’ Krishna Chaitanya, MBBS, MSc (Clinical Embryology) Scientific Head and Clinical Embryologist Oasis Fertility β’ Jyoti Budi, Medical Director at Ferty9 Fertility β’ Keshav Malhotra, Lab Director and Chief Embryologist ART Rainbow IVF, Vice Chair Embryology ISAR, Chair Embryology SIG ASPIRE, EC Member - ALPHA, ACE |
Moderators: Sankalp Singh Founder and Director,Yaami Fertility and IVF center, Indore Vandana Hegde Clinical Director, Chief IVF Consultant at Hegde Fertility, a Unit of Hegde Hospital |
| 13:20β14:00 | Lunch Break | |
| 14:00β14:40 |
Panel Discussion: Fertility Frontlines: Industry Perspectives on the Future of IVF Labs in India Insights from Pharma, Device, and Consumables Leaders on Innovation, Access, and Market Growth Panellists: β’ Jaikanth M, Chief Financial Officer, SAR Healthline Pvt Ltd β’ Ashish Modi, CEO & Medical Inventor Shivani Scientific Industries Pvt Ltd β’ Amit Bhatnagar, Vice President Asia Pacific Fertility Solutions CooperSurgical β’ Vivek Soares, Country Lead, India & South Asia Organon Asia Pacific β’ Mahabaleshwar Kotabagi, Director, Samarth Life Sciences Pvt Ltd β’ Dileep Sasi, BU Head, Fertility division, Cipla |
Moderators: Alex C Varghese Director β Research & Innovation, Fertility Associates, New Zealand Chandrasekar S, CEO, Oval fertility |
| 14:40β15:10 |
Financial Fitness for Doctors β Personal Wealth Planning & Risk Management Core financial planning for clinicians including insurance, investments, FIRE strategy, and tools to manage personal and professional finances. |
Nitin Jagtap Consultant Gastroenterologist AIG Hospitals |
| 15:10β15:30 | The Billionaire Mindset in Fertility Business β The entrepreneur: wealth thinking, diversification, long-term brand value. | Vinesh Gadhia Executive Director & CEO Fert9 Center |
| 15:30β15:40 | Select Q&A β 10 minutes | |
| 15:40β16:00 | Coffee Break | |
| Corporate Culture and the Human Side of Scale Leadership beyond structure: aligning values, better patient experience, retaining talent, and building a mission-driven team. | ||
| 16:00β16:20 |
Talk 1: Investing in People β Building a Happy Workforce People Before Protocols: Building a Culture That Retains and Empowers Strategies for creating a motivated, loyal, and productive IVF workforce. |
Sures M CEO Sunfert International, Malaysia |
| 16:20β16:40 |
Talk 2: Investing in Patients β Personalizing the IVF Journey The Personal Touch at Scale: Retaining Patients in a Crowded Market How customized communication and regional understanding enhance patient loyalty. |
Veena Reddy Co-Founder Oval Fertility (GVK Group) |
| 16:40β16:50 | Select Q&A β 10 minutes | |
| 16:50β17:40 |
Clinic Confidential: Open Q&A and Strategic Cross-Talk with the Experts Session Format: An informal, interactive closing session designed to foster candid conversations and practical takeaways. This is a unique opportunity for participants to: β’ Ask specific questions related to clinic ownership, IVF business strategy, exit planning, or scaling models β’ Gain tailored advice on financial planning, equity investment, branding, or operational optimization β’ Learn from the journeys of successful founders, investors, and executives β’ Explore real-life challenges and get direct input from panelists in a consultative, peer-learning format |
Moderator: Sanketh Dhumal, Head Embryology, Oval Fertility, Hyderabad Dr. (Col) Sandeep Karunakaran Medical Director, Oval Fertility, Hyderabad |
| 17:40β18:00 | Closing remarks | |